# Safety and Efficacy Study to Treat Bacterial Vaginosis

> **NCT01621399** · PHASE3 · COMPLETED · sponsor: **Medicis Global Service Corporation** · enrollment: 651 (actual)

## Conditions studied

- Bacterial Vaginosis

## Interventions

- **DRUG:** Product 55394
- **DRUG:** Placebo Vehicle (non-treatment)

## Key facts

- **NCT ID:** NCT01621399
- **Lead sponsor:** Medicis Global Service Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 651 (ACTUAL)
- **Last updated:** 2013-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01621399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01621399, "Safety and Efficacy Study to Treat Bacterial Vaginosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01621399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*